🇺🇸 FDA
Patent

US 7871981

Inhibition of cell motility, angiogenesis, and metastasis

granted A61KA61K38/05A61K38/06

Quick answer

US patent 7871981 (Inhibition of cell motility, angiogenesis, and metastasis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/05, A61K38/06, A61K38/07, A61P